RightEye test uses NIR illumination to help determine head trauma severity quickly
A concussion test uses near-infrared light to illuminate the eyes and advanced sensors (a camera) to take rapid images.
Medical device maker RightEye (Bethesda, MD) has launched its RightEye Neuro Vision concussion test that helps healthcare providers more clearly understand the severity of a patient’s head trauma and better assess their recovery over time. The test's eye tracking technology uses near-infrared light to illuminate the eyes and advanced sensors (a camera) to take rapid images of the eyes.
Related: OCT system helps discover ocular changes in astronauts
The eye-tracked, digital test is based on the smooth pursuit protocol, which is a manual concussion test used by physicians to determine if a person’s eyes are able to closely follow a moving object. The company has taken this subjective manual examination that requires observation of the patient’s eyes and has created a 15 s test that is objective, repeatable, and comparable over time, and lets healthcare providers discover more about an individual’s health.
The patient, while sitting in front of a computer that has a small eye tracking bar attached at the bottom of the screen, simply watches a circular digital animation for 15 s. Immediately following the test, the system automatically e-mails a report to the healthcare provider and patient that shows the eye-tracked digitization of the results and associated metrics.
The device, which was showcased at the 2015 American Academy of Optometry (AAO) meeting held October 7-10, 2015, in New Orleans, LA, is delivered in a portable hardware package with a web-based software interface, and ranges from $595 to $995 on a monthly licensing basis.
IMG Academy (Bradenton, FL), a sports training center that serves pre-professional baseball players, plans to use the device to measure how quickly a batter can see and then react to the spin of a baseball.
For more information, please visit www.righteye.com.
Follow us on Twitter, 'like' us on Facebook, connect with us on Google+, and join our group on LinkedIn